Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: A randomized, double-blind trial

Journal of Dermatological Treatment

Volumn 16, Issue 5-6, 2005, Pages 331-335

  Singal, Archana ^a   Pandhi, Deepika ^a,b   Agrawal, Subhav ^a   Das, Shukla ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

Butenafine; Clotrimazole; Comparative efficacy; Tinea corporis; Tinea cruris

Indexed keywords

BUTENAFINE; CLOTRIMAZOLE; POTASSIUM HYDROXIDE;

ADOLESCENT; ADULT; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL ASSESSMENT; MYCOLOGY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TINEA CORPORIS; TINEA CRURIS;

ADMINISTRATION, TOPICAL; ADULT; ANTIFUNGAL AGENTS; BENZYLAMINES; CLOTRIMAZOLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NAPHTHALENES; TINEA; TREATMENT OUTCOME;

EID: 31644440684     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630500375783     Document Type: Article

References (10)

1. Crissey JT. Common dermatophyte infections: a simple diagnostic test and current management. Postgrad Med. 1998;103:191-2.
2. Pierard GE, Arrese JE, Pierard-Franchimont C. Treatment and prophylaxis of tinea infections. Drugs. 1996;52:209-24.
3. Elewski BE. Mechanisms of action of systemic antifungal agents. J Am Acad Dermatol. 1993;28:S28-S34.
4. McNeely W, Spencer CM. Butenafine. Drugs. 1998;55:405-12.
5. Lesher JL Jr, Babel DE, Stewart DM, Jones TM, Kaminester L, Goldman M, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial. J Am Acad Deramatol. 1997;36:S20-S24.
6. Arika J, Hase J, Yokoo M. Antitrichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs. Antimicrob Agents Chemother. 1993;37:363-5.
7. Arika T, Yokoo M, Hase T, Maeda T, Amemiya K, Yamaguchi H. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs. Antimicrob Agents Chemother. 1990;34:2250-3.
8. Savin R, De Villez RL, Elewski B, Hong S, Jones T, Lucky A, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. J Am Acad Dermatol. 1997;36:S15-S19.
9. Greer DL, Weiss J, Rodriguez DA, Hebert AA, Swinehart JM. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent. J Am Acad Dermatol. 1997;37:231-5.
10. Berman B, Ellis C, Leyden J, Lowe N, Savin R, Shupack J. Efficacy of a 1-week twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. J Am Acad Dermatol. 1992;26:956-60.